Company news

SIGA Technologies Inc. news in 2021

SIGA Technologies Inc.'s news releases, calls and decks from 2021, newest first.

View company

SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®

November 30, 2021

European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat

November 15, 2021

SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021

November 3, 2021

SIGA Technologies to Host Business Update Call on November 4th, 2021, Following Release of Third Quarter 2021 Financial Results

October 27, 2021

SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX®

September 12, 2021

SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021

September 6, 2021

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

August 4, 2021

SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results

July 28, 2021

SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic

July 28, 2021

SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom

June 29, 2021

SIGA Reports Financial Results for Three Months Ended March 31, 2021

May 5, 2021

SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX

May 3, 2021

SIGA Technologies to Host Business Update Call on May 6th, 2021 Following Release of First Quarter 2021 Financial Results

April 28, 2021

Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

March 22, 2021

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020

March 3, 2021

SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results

February 25, 2021

SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®

January 12, 2021

Calls in 2021